Fulcrum Therapeutics Inc (FULC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 80,000 | 0 | 871 | 759 | 880 |
| Gross Profit | 80,000 | N/A | 871 | 759 | 880 |
| Operating Expenses | 27,508 | 29,834 | 28,863 | 28,199 | 28,172 |
| Operating Income | 52,492 | -29,834 | -27,992 | -27,440 | -27,292 |
| Other Income | 2,917 | 2,964 | 3,236 | 3,423 | 3,509 |
| Pre-tax Income | 55,409 | -26,870 | -24,756 | -24,017 | -23,783 |
| Net Income Continuous | 55,409 | -26,870 | -24,756 | -24,017 | -23,783 |
| Net Income | $55,409 | $-26,870 | $-24,756 | $-24,017 | $-23,783 |
| EPS Basic Total Ops | 0.89 | -0.43 | -0.41 | -0.39 | -0.38 |
| EPS Basic Continuous Ops | 0.89 | -0.43 | -0.40 | -0.39 | -0.38 |
| EPS Diluted Total Ops | 0.87 | -0.43 | -0.41 | -0.39 | -0.38 |
| EPS Diluted Continuous Ops | 0.87 | -0.43 | -0.40 | -0.39 | -0.38 |
| EPS Diluted Before Non-Recurring Items | 0.87 | -0.43 | -0.40 | N/A | N/A |
| EBITDA(a) | $52,868 | $-29,355 | $-27,484 | $-26,909 | $-26,725 |